Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vered Abitbol

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Joint Bone Spine|December 3, 2014
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosisKarine Briot, Bernard Cortet, Christian Roux, et al.
Clinics and Research in Hepatology and Gastroenterology|January 12, 2020
Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort studyNicolas Petitdidier, Laurent Beaugerie, Franck Carbonnel, et al.
Open Forum Infectious Diseases|July 3, 2024
Tuberculosis and Immune Reconstitution Inflammatory Syndrome in Patients With Inflammatory Bowel Disease and Anti-TNFα Treatment: Insights From a French Multicenter Study and Systematic Literature Review With Emphasis on Paradoxical Anti-TNFα ResumptionAriane Amoura, Thomas Frapard, Xavier Treton, et al.
Inflammatory Bowel Diseases|February 7, 2013
Portomesenteric vein thrombosis in patients with inflammatory bowel diseaseCécilia Landman, Stéphane Nahon, Jacques Cosnes, et al.
The American Journal of Gastroenterology|August 6, 2014
Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAIDAurelien Amiot, Vida Setakhr, Philippe Seksik, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 25, 2024
Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER StudyGuillaume Bouguen, Laure Gossec, Vered Abitbol, et al.
Infection Prevention in Practice|January 5, 2023
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control studyAurelien Amiot, Anne Bourrier, Jean-Marc Gornet, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
Alimentary Pharmacology & Therapeutics|August 3, 2018
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)Charlotte Gagnière, Anne Bourrier, Philippe Seksik, et al.
Endoscopy International Open|December 22, 2018
Impact of a dedicated multidisciplinary meeting on the management of superficial cancers of the digestive tractSolène Dermine, Maximilien Barret, Caroline Prieux, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Joint Bone Spine|December 3, 2014
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosisKarine Briot, Bernard Cortet, Christian Roux, et al.
Clinics and Research in Hepatology and Gastroenterology|January 12, 2020
Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort studyNicolas Petitdidier, Laurent Beaugerie, Franck Carbonnel, et al.
Open Forum Infectious Diseases|July 3, 2024
Tuberculosis and Immune Reconstitution Inflammatory Syndrome in Patients With Inflammatory Bowel Disease and Anti-TNFα Treatment: Insights From a French Multicenter Study and Systematic Literature Review With Emphasis on Paradoxical Anti-TNFα ResumptionAriane Amoura, Thomas Frapard, Xavier Treton, et al.
Inflammatory Bowel Diseases|February 7, 2013
Portomesenteric vein thrombosis in patients with inflammatory bowel diseaseCécilia Landman, Stéphane Nahon, Jacques Cosnes, et al.
The American Journal of Gastroenterology|August 6, 2014
Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAIDAurelien Amiot, Vida Setakhr, Philippe Seksik, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 25, 2024
Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER StudyGuillaume Bouguen, Laure Gossec, Vered Abitbol, et al.
Infection Prevention in Practice|January 5, 2023
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control studyAurelien Amiot, Anne Bourrier, Jean-Marc Gornet, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
Alimentary Pharmacology & Therapeutics|August 3, 2018
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)Charlotte Gagnière, Anne Bourrier, Philippe Seksik, et al.
Endoscopy International Open|December 22, 2018
Impact of a dedicated multidisciplinary meeting on the management of superficial cancers of the digestive tractSolène Dermine, Maximilien Barret, Caroline Prieux, et al.
Pageof 9